Cargando…

Intrapleural Instillation of Sodium Bicarbonate versus Urokinase in Management of Complicated Pleural Effusion: A Comparative Cohort Study

AIM: The main target is evacuation; however, with evidence about the value of intrapleural instillation of different fibrinolytic agents still under evaluation, our aim was comparing the effectiveness and safety of intrapleural instillation of sodium bicarbonate (NaHCO(3)) in comparison with urokina...

Descripción completa

Detalles Bibliográficos
Autores principales: Zayed, Niveen E, El Fakharany, Karim, Mehriz Naguib Abozaid, Mohammed
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9790168/
https://www.ncbi.nlm.nih.gov/pubmed/36575733
http://dx.doi.org/10.2147/IJGM.S388488
_version_ 1784859114729373696
author Zayed, Niveen E
El Fakharany, Karim
Mehriz Naguib Abozaid, Mohammed
author_facet Zayed, Niveen E
El Fakharany, Karim
Mehriz Naguib Abozaid, Mohammed
author_sort Zayed, Niveen E
collection PubMed
description AIM: The main target is evacuation; however, with evidence about the value of intrapleural instillation of different fibrinolytic agents still under evaluation, our aim was comparing the effectiveness and safety of intrapleural instillation of sodium bicarbonate (NaHCO(3)) in comparison with urokinase in patients with infected pleural effusion. METHODS: Our prospective cohort study included 40 patients with complicated empyema; the diagnosis was based on analysis of aspirated fluid in association with radiological and bacteriological culture. The patients were subjected to instillation of two different fibrinolytic agents; the first one was NaHCO(3), the second was urokinase. RESULTS: The commonest underlying chest infection that was visualized by CT was pneumonia 70%. Nearly half of cases had community-acquired infection (45%), and more than half of them (55%) had anaerobic infection, and only five cases had TB pleural effusion based on ADA-positive, tuberculin skin test in addition to Abram’s needles closed biopsy. The rate of repeated therapeutic thoracentesis success in each group was 85%; 80% in NaHCO(3) group, and 90% in urokinase group, both of them was significantly equal, P=0.37. Moreover, the frequency of complications in all patients was less than 13%, hence hemothorax and iatrogenic pneumothorax was 12.5%, and only 10% of cases were admitted in ICU after the maneuver, with insignificant difference in between the groups. However, looking at the smaller rate of RTT failure of NaHCO(3) or urokinase, the logistic regression model showed that RTT–NaHCO(3) was insignificantly related to failure in both unadjusted and adjusted models, P=0.37 and 0.32, respectively, and only smoking habits increase the likelihood of failure 9-fold (OR=8.9, P=0.04) with respect to age, sex, and treatment methods. CONCLUSION: The efficacy of repeated therapeutic thoracentesis (RTT) with intrapleural instillation of NaHCO(3) was effective and safe, the same as urokinase, with consideration that NaHCO(3) was much more available and affordable than urokinase.
format Online
Article
Text
id pubmed-9790168
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Dove
record_format MEDLINE/PubMed
spelling pubmed-97901682022-12-26 Intrapleural Instillation of Sodium Bicarbonate versus Urokinase in Management of Complicated Pleural Effusion: A Comparative Cohort Study Zayed, Niveen E El Fakharany, Karim Mehriz Naguib Abozaid, Mohammed Int J Gen Med Original Research AIM: The main target is evacuation; however, with evidence about the value of intrapleural instillation of different fibrinolytic agents still under evaluation, our aim was comparing the effectiveness and safety of intrapleural instillation of sodium bicarbonate (NaHCO(3)) in comparison with urokinase in patients with infected pleural effusion. METHODS: Our prospective cohort study included 40 patients with complicated empyema; the diagnosis was based on analysis of aspirated fluid in association with radiological and bacteriological culture. The patients were subjected to instillation of two different fibrinolytic agents; the first one was NaHCO(3), the second was urokinase. RESULTS: The commonest underlying chest infection that was visualized by CT was pneumonia 70%. Nearly half of cases had community-acquired infection (45%), and more than half of them (55%) had anaerobic infection, and only five cases had TB pleural effusion based on ADA-positive, tuberculin skin test in addition to Abram’s needles closed biopsy. The rate of repeated therapeutic thoracentesis success in each group was 85%; 80% in NaHCO(3) group, and 90% in urokinase group, both of them was significantly equal, P=0.37. Moreover, the frequency of complications in all patients was less than 13%, hence hemothorax and iatrogenic pneumothorax was 12.5%, and only 10% of cases were admitted in ICU after the maneuver, with insignificant difference in between the groups. However, looking at the smaller rate of RTT failure of NaHCO(3) or urokinase, the logistic regression model showed that RTT–NaHCO(3) was insignificantly related to failure in both unadjusted and adjusted models, P=0.37 and 0.32, respectively, and only smoking habits increase the likelihood of failure 9-fold (OR=8.9, P=0.04) with respect to age, sex, and treatment methods. CONCLUSION: The efficacy of repeated therapeutic thoracentesis (RTT) with intrapleural instillation of NaHCO(3) was effective and safe, the same as urokinase, with consideration that NaHCO(3) was much more available and affordable than urokinase. Dove 2022-12-21 /pmc/articles/PMC9790168/ /pubmed/36575733 http://dx.doi.org/10.2147/IJGM.S388488 Text en © 2022 Zayed et al. https://creativecommons.org/licenses/by-nc/3.0/This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/ (https://creativecommons.org/licenses/by-nc/3.0/) ). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).
spellingShingle Original Research
Zayed, Niveen E
El Fakharany, Karim
Mehriz Naguib Abozaid, Mohammed
Intrapleural Instillation of Sodium Bicarbonate versus Urokinase in Management of Complicated Pleural Effusion: A Comparative Cohort Study
title Intrapleural Instillation of Sodium Bicarbonate versus Urokinase in Management of Complicated Pleural Effusion: A Comparative Cohort Study
title_full Intrapleural Instillation of Sodium Bicarbonate versus Urokinase in Management of Complicated Pleural Effusion: A Comparative Cohort Study
title_fullStr Intrapleural Instillation of Sodium Bicarbonate versus Urokinase in Management of Complicated Pleural Effusion: A Comparative Cohort Study
title_full_unstemmed Intrapleural Instillation of Sodium Bicarbonate versus Urokinase in Management of Complicated Pleural Effusion: A Comparative Cohort Study
title_short Intrapleural Instillation of Sodium Bicarbonate versus Urokinase in Management of Complicated Pleural Effusion: A Comparative Cohort Study
title_sort intrapleural instillation of sodium bicarbonate versus urokinase in management of complicated pleural effusion: a comparative cohort study
topic Original Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9790168/
https://www.ncbi.nlm.nih.gov/pubmed/36575733
http://dx.doi.org/10.2147/IJGM.S388488
work_keys_str_mv AT zayedniveene intrapleuralinstillationofsodiumbicarbonateversusurokinaseinmanagementofcomplicatedpleuraleffusionacomparativecohortstudy
AT elfakharanykarim intrapleuralinstillationofsodiumbicarbonateversusurokinaseinmanagementofcomplicatedpleuraleffusionacomparativecohortstudy
AT mehriznaguibabozaidmohammed intrapleuralinstillationofsodiumbicarbonateversusurokinaseinmanagementofcomplicatedpleuraleffusionacomparativecohortstudy